BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 30060283)

  • 1. [Pancreatic Cancer in the Year 2018 - Room for Precision Medicine?].
    Simon O; Beyer G; Mahajan UM; Mayerle J
    Dtsch Med Wochenschr; 2018 Aug; 143(15):1109-1112. PubMed ID: 30060283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant therapy for pancreatic cancer: current status and future directions.
    Xiong HQ; Abbruzzese JL
    Surg Oncol Clin N Am; 2004 Oct; 13(4):737-49, xi. PubMed ID: 15350945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on the management of pancreatic cancer: surgery is not enough.
    Ansari D; Gustafsson A; Andersson R
    World J Gastroenterol; 2015 Mar; 21(11):3157-65. PubMed ID: 25805920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatic cancer: future outlook, promising trials, newer systemic agents, and strategies from the Gastrointestinal Intergroup Pancreatic Cancer Task Force.
    Jafari M; Abbruzzese JL
    Surg Oncol Clin N Am; 2004 Oct; 13(4):751-60, xi. PubMed ID: 15350946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Borderline resectable pancreatic cancer-At the crossroads of precision medicine.
    Katz MHG; Varadhachary GR
    Cancer; 2019 May; 125(10):1584-1587. PubMed ID: 30673119
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of surgery in pancreatic cancer.
    Buanes TA
    World J Gastroenterol; 2017 Jun; 23(21):3765-3770. PubMed ID: 28638216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cisplatin, fluorouracil, interferon-alpha, and radiation as adjuvant therapy for resected pancreatic cancer: is there a future for this regimen and/or should we change our approach to research and treatment of patients with pancreatic cancer?
    Pisters PW; Evans DB
    Ann Surg; 2008 Aug; 248(2):152-3. PubMed ID: 18650622
    [No Abstract]   [Full Text] [Related]  

  • 8. The Virginia Mason approach to localized pancreatic cancer.
    Picozzi VJ; Traverso LW
    Surg Oncol Clin N Am; 2004 Oct; 13(4):663-74, ix. PubMed ID: 15350940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical overview of the current status of treatment of pancreatic cancer: oncological point of view.
    Szawłowski AW
    Przegl Lek; 2000; 57 Suppl 5():20-1. PubMed ID: 11202284
    [No Abstract]   [Full Text] [Related]  

  • 10. Neoadjuvant therapy for pancreatic cancer: the Duke experience.
    White RR; Tyler DS
    Surg Oncol Clin N Am; 2004 Oct; 13(4):675-84, ix-x. PubMed ID: 15350941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies to improve the outcome in locally advanced pancreatic cancer.
    Späth C; Nitsche U; Müller T; Michalski C; Erkan M; Kong B; Kleeff J
    Minerva Chir; 2015 Apr; 70(2):97-106. PubMed ID: 25658301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multifocal anaplastic pancreatic carcinoma requiring neoadjuvant chemotherapy and total pancreatectomy: report of a case.
    Jones TS; Jones EL; McManus M; Shah R; Gajdos C
    JOP; 2013 May; 14(3):289-91. PubMed ID: 23669483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New challenges in perioperative management of pancreatic cancer.
    Puleo F; Maréchal R; Demetter P; Bali MA; Calomme A; Closset J; Bachet JB; Deviere J; Van Laethem JL
    World J Gastroenterol; 2015 Feb; 21(8):2281-93. PubMed ID: 25741134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of lymph node positivity in treatment planning for early stage pancreatic cancer.
    Tran Cao HS; Zhang Q; Sada YH; Silberfein EJ; Hsu C; Van Buren G; Chai C; Katz MHG; Fisher WE; Massarweh NN
    Surgery; 2017 Sep; 162(3):557-567. PubMed ID: 28666686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoadjuvant therapy for resectable pancreatic cancer.
    Raut CP; Evans DB; Crane CH; Pisters PW; Wolff RA
    Surg Oncol Clin N Am; 2004 Oct; 13(4):639-61, ix. PubMed ID: 15350939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic Diversity of Pancreatic Ductal Adenocarcinoma and Opportunities for Precision Medicine.
    Knudsen ES; O'Reilly EM; Brody JR; Witkiewicz AK
    Gastroenterology; 2016 Jan; 150(1):48-63. PubMed ID: 26385075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perspectives in the treatment of pancreatic adenocarcinoma.
    Cid-Arregui A; Juarez V
    World J Gastroenterol; 2015 Aug; 21(31):9297-316. PubMed ID: 26309356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidisciplinary management of locally advanced pancreatic ductal adenocarcinoma.
    Alemi F; Alseidi A; Scott Helton W; Rocha FG
    Curr Probl Surg; 2015 Sep; 52(9):362-98. PubMed ID: 26363649
    [No Abstract]   [Full Text] [Related]  

  • 19. [Locoregional and systemic therapy of advanced pancreatic carcinoma].
    Gebauer T; Ridwelski K; Fahlke J; Lippert H
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():1344-7. PubMed ID: 9931877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The multidisciplinary management of gastrointestinal cancer. Pancreatic cancer: from pathogenesis to cure.
    Ducreux M; Boige V; Goéré D; Deutsch E; Ezra P; Elias D; Malka D
    Best Pract Res Clin Gastroenterol; 2007; 21(6):997-1014. PubMed ID: 18070700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.